← Back to Clinical Trials
Recruiting NCT06726629

NCT06726629 Crosscultural Adaptation And Validation Of The Italian Version Of The New Knee Society Knee Scoring System

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06726629
Status Recruiting
Phase
Sponsor Istituto Ortopedico Rizzoli
Condition Knee Osteoarthritis
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-11-01
Primary Completion 2026-11

Trial Parameters

Condition Knee Osteoarthritis
Sponsor Istituto Ortopedico Rizzoli
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2024-11-01
Completion 2026-11
Interventions
Version Of The New Knee Society Knee Scoring System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The present study aims to be a multicenter prospective analysis aimed at validating the Italian version of the new KSS introduced in 2011 15. To do this it is first necessary to create the translation of the questionnaire. Several steps will be performed to obtain an adequate Italian version of the new KSS: 1. The English version of the KSS will be translated into Italian by 3 bilingual translators 2. The 2 versions will be submitted to the study collaborators (one per centre), the final version (accepted by all the study collaborators) will be translated back into English by 2 bilingual translators (native English) not aware of the initial version. The back translation will then be sent to the original author (Prof. Scott) to ensure that the consistency of the questionnaire has been maintained throughout all processes despite the necessary cultural adaptations. 3. Once the definitive version has been obtained, it will be tested by 300 Italian patients (with an estimated dropout of 20%) suffering from gonarthrosis. The patients will be distributed as follows: approximately 50 patients in each of the 6 centers (total 300). The number of patients was chosen considering approximately 17-18 patients for each of the 17 items, this choice is consistent with previously published studies on translation into other languages

Eligibility Criteria

Inclusion Criteria: * Diagnosis of gonarthrosis and indication for primary TKA surgery * Age between 18 and 85 years * Ability to respond to the proposed questionnaires and provide informed consent * Availability for follow-up for one year after surgery Exclusion Criteria: * Concomitant hip or spinal problems, understood as a cause of patient discomfort even if not yet undergoing medical or rehabilitation therapy * History of ipsilateral or contralateral knee surgery * Congenital knee deformities * Previous septic arthritis * Neuromuscular pathology (e.g. polio) * Simultaneous bilateral prosthesis or within 12 months of both knee, hip and ankle

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology